![Eric Rubin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Rubin
Direktor/Vorstandsmitglied bei
NATERA, INC.
Vermögen: 598 276 $ am 30.06.2026
Profil
Dr. Eric H.
Rubin, MD, is an Independent Director at Natera, Inc. He is on the Board of Directors at Natera, Inc. Dr. Rubin was previously employed as an Independent Director by Oncorus, Inc., a Senior VP-Global Clinical Oncology by Merck & Co., Inc., a Member by American Cancer Society, Inc., a Member by National Cancer Institute, and a Director-Investigational Therapeutics Division by Rutgers Cancer Institute of New Jersey.
He received his undergraduate degree from Tulane University (Louisiana) and a doctorate degree from the University of South Florida.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.06.2026 | 2’204 ( 0% ) | 598 276 $ | 30.06.2026 |
Aktive Positionen von Eric Rubin
| Unternehmen | Position | Beginn |
|---|---|---|
| NATERA, INC. | Direktor/Vorstandsmitglied | 26.03.2026 |
Ehemalige bekannte Positionen von Eric Rubin
| Unternehmen | Position | Ende |
|---|---|---|
| ONCORUS, INC. | Direktor/Vorstandsmitglied | 28.07.2023 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.01.2023 |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Corporate Officer/Principal | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
The Cancer Institute of New Jersey
 The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Operates cancer center | Corporate Officer/Principal | - |
Ausbildung von Eric Rubin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
49
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
The Cancer Institute of New Jersey
The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Operates cancer center | Health Services |
Natera, Inc.
 Natera, Inc. BiotechnologyHealth Technology Engages in development and commercialization of molecular testing and technology services in the fields of women’s, oncology and organ health | Health Technology |
Oncorus, Inc.
 Oncorus, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops next generation immunotherapy platform to treat cancer | Health Technology |
